All the news of Physidia

 Webinar THE FUTURE IS AT HOME Hosted by Pr. Bernard Canaud   PURPOSE • A better life lived through home hemodialysis - Dr Albert Power, National Clinical Advisor for Dialysis - Renal Service Transformation Program, NHS ; Bristol University Hospital, England...

 The International Society for Hemodialysis (ISHD) will be live on Saturday, October 9th, and we'll be there! The Physidia team is looking forward to presenting you our S3 Technology!   PURPOSE The growth of Home Hemodialysis (HHD) continues to remain...

 SYMPOSIUM: "Physidia’s S3 system, a solution for frequent hemodialyis at home" On September 23rd, UK Dialysis Conference, Manchester   Physidia is presenting its home hemodialysis therapy to the 13th UK Dialysis Conference, in Manchester. Come to visit our...

The aim of the first agreement is the exclusive distribution of Physidia’s S3 system for frequent home hemodialysis therapy on the Italian market.

Physidia announces a new distributor agreement with Nordic Medcom AB Physidia, the European leader in frequent home hemodialysis, announces the signature of an exclusive distribution agreement with Nordic Medcom for Sweden, Finland, Denmark, and NorwayPhysidia,...

Physidia Live Webinar Series on Frequent Home hemodialysis: “Introducing the Physidia S3 system: an optimized solution for frequent hemodialysis at home” > Webinar Replay Physidia Live Webinar Series on Frequent Home hemodialysis: “Introducing the Physidia S3...

 PHYSIDIA ANNOUNCES MAJOR ACHIEVEMENTS FOR 2020 Physidia, the European leader in frequent home hemodialysis, announces exponential growth and major achievements for 2020 2020 confirms Physidia’s exceptional results in a fast-growing environment. The company,...

Baxter SAS and Physidia sign a co-promotion agreement to support homecare for dialysis patients in France Baxter SAS and Physidia sign a co-promotion agreement to support homecare for dialysis patients in FranceAs part of a co-promotion agreement, Baxter SAS and...

 SINGLE SESSION and WEEKLY BETA 2 MICROGLOBULIN REMOVAL DURING SHORT FREQUENT HEMODIALYSIS USING PHYSIDIA TECHNOLOGY Physidia publication at the 2021 ADC conference β2M removal – a study on efficiency of middle molecules elimination with short frequent...

26.06.2019 Redsense signs collaboration agreement with Physidia to increase patient safety for home hemodialysis patients.   Physidia is the second dialysis monitor manufacturer to include a direct connection to Redsense in accordance with the PAS 63023...